STOCK ALERT: Rosen Law Firm Reminds GW Pharmaceuticals plc Investors of Important Deadline in Class Action – GWPH
February 10 2016 - 2:41PM
Business Wire
Rosen Law Firm, a global investor rights law firm, reminds
purchasers of GW Pharmaceuticals plc securities (NASDAQ: GWPH) from
December 4, 2014 through January 8, 2016, both dates inclusive (the
“Class Period”) of the important March 21, 2016 lead plaintiff
deadline. The lawsuit seeks to recover damages for GW
Pharmaceuticals investors under the federal securities laws.
To join the GW Pharmaceuticals class action, go to the firm’s
website at http://rosenlegal.com/cases-821.html or call Phillip
Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for information on the
class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period,
Defendants issued materially false and misleading statements to
investors and/or failed to disclose that: (1) GW Pharmaceuticals
lacked effective internal financial controls; (2) GW
Pharmaceuticals lacked effective controls over completeness and
valuation of clinical trial accruals; and (3) as a result,
Defendants’ statements about GW Pharmaceuticals’ business,
operations, and prospects were false and misleading and/or lacked a
reasonable basis at all relevant times. When the true details
entered the market, the lawsuit claims that investors suffered
damages.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
March 21, 2016. A lead plaintiff is a representative party acting
on behalf of other class members in directing the litigation. If
you wish to join the litigation, go to the firm’s website at
http://rosenlegal.com/cases-821.html or to discuss your rights or
interests regarding this class action, please contact Phillip Kim,
Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at
866-767-3653 or via e-mail at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation. Attorney Advertising. Prior
results do not guarantee a similar outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160210006487/en/
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212)
202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Apr 2024 to May 2024
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From May 2023 to May 2024